Enveric Biosciences (ENVB)
(Delayed Data from NSDQ)
$0.90 USD
+0.03 (3.15%)
Updated Apr 23, 2024 04:00 PM ET
After-Market: $0.88 -0.02 (-1.94%) 6:16 PM ET
1-Strong Buy of 5 1
F Value C Growth C Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 5/20/24 |
---|---|
Current Quarter | -0.61 |
EPS Last Quarter | -1.46 |
Last EPS Surprise | 5.81% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -1.98 |
Next Year | -1.02 |
EPS (TTM) | -8.02 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | 10.00M |
# of Estimates | NA | NA | NA | 1 |
High Estimate | NA | NA | NA | 10.00M |
Low Estimate | NA | NA | NA | 10.00M |
Year ago Sales | 0.00M | 0.00M | NA | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.61 | -0.55 | -1.98 | -1.02 |
# of Estimates | 1 | 1 | 2 | 2 |
Most Recent Consensus | -0.61 | -0.55 | -2.08 | -1.41 |
High Estimate | -0.61 | -0.55 | -1.87 | -0.63 |
Low Estimate | -0.61 | -0.55 | -2.08 | -1.41 |
Year ago EPS | -2.22 | -3.04 | -8.01 | -1.98 |
Year over Year Growth Est. | 72.52% | 81.91% | 75.28% | 48.23% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 1 | 1 | 1 | 0 |
Up Last 60 Days | 1 | 1 | 1 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.61 | -0.55 | -1.98 | -1.02 |
7 Days Ago | -0.61 | -0.55 | -1.98 | -1.02 |
30 Days Ago | -1.28 | -0.79 | -2.66 | -0.63 |
60 Days Ago | -1.28 | -0.79 | -2.66 | -0.63 |
90 Days Ago | -1.28 | -0.79 | -3.44 | NA |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.61 | -0.55 | -2.08 | -1.41 |
Zacks Consensus Estimate | -0.61 | -0.55 | -1.98 | -1.02 |
Earnings ESP | 0.00% | 0.00% | -5.32% | -38.24% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -1.46 | -1.30 | -3.04 | -2.22 | NA |
Estimate | -1.55 | -1.93 | NA | NA | NA |
Difference | 0.09 | 0.63 | NA | NA | 0.36 |
Surprise | 5.81% | 32.64% | NA | NA | 19.23% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more